Insider NameBuy/SellCompany NameTickerAmountShares Change
Jul 30, 2025Aug 01, 2025Patel Sushil Amathalal
Dir
BuyPlumas BancorpPLBC$41.16$53,502+26.08%
May 20, 2025May 23, 2025Patel Sushil
CEO
SellReplimune Group, Inc.REPL$8.06$202,346-6.81%
Dec 16, 2024Dec 19, 2024Patel Sushil
CEO
SellReplimune Group, Inc.REPL$12.42$124,200-4.72%
Oct 31, 2024Nov 04, 2024Patel Sushil
Dir
SellRevolution Medicines, Inc.RVMD$54.14$270,715-20.04%
Jul 09, 2024Jul 10, 2024Patel Sushil
Dir
SellRevolution Medicines, Inc.RVMD$44$94,820-9.75%
May 20, 2024May 22, 2024Patel Sushil Amathalal
Dir
BuyPlumas BancorpPLBC$35.63$48,954+50.00%
May 16, 2024May 21, 2024Patel Sushil
CEO
SellReplimune Group, Inc.REPL$6.47$130,655-8.70%
Apr 10, 2024Apr 12, 2024Patel Sushil
Dir
SellRevolution Medicines, Inc.RVMD$37$79,735-12.07%
Jun 13, 2023Jun 16, 2023Patel Sushil
Chief Strategy Officer
SellReplimune Group, Inc.REPL$24.05$137,008-3.69%
May 16, 2023May 19, 2023Patel Sushil
Chief Strategy Officer
SellReplimune Group, Inc.REPL$18.05$281,129-9.15%
May 16, 2022May 18, 2022Patel Sushil
Chief Commercial Officer
SellReplimune Group, Inc.REPL$14.59$155,923-7.59%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.